GLP-1’s Drove Eli Lilly’s Record-Breaking Q2, but AI Will Be Its Future
Eli Lilly just posted one of the most impressive quarters in pharmaceutical history, but the drug powering those numbers may not be what defines the company a decade from now. A billion-dollar bet on…


















